These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21617876)

  • 1. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
    Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
    Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
    Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
    Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
    Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
    J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.
    Wang SJ; Bourguignon LY
    Am J Pathol; 2011 Mar; 178(3):956-63. PubMed ID: 21356346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
    Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
    Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.
    Sayed SI; Dwivedi RC; Katna R; Garg A; Pathak KA; Nutting CM; Rhys-Evans P; Harrington KJ; Kazi R
    Oral Oncol; 2011 Apr; 47(4):237-43. PubMed ID: 21382740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
    Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
    Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
    Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.
    Lim YC; Oh SY; Cha YY; Kim SH; Jin X; Kim H
    Oral Oncol; 2011 Feb; 47(2):83-91. PubMed ID: 21167769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
    Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
    Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.
    Chikamatsu K; Ishii H; Takahashi G; Okamoto A; Moriyama M; Sakakura K; Masuyama K
    Head Neck; 2012 Mar; 34(3):336-43. PubMed ID: 21472882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.
    Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A
    Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma.
    Chinn SB; Darr OA; Owen JH; Bellile E; McHugh JB; Spector ME; Papagerakis SM; Chepeha DB; Bradford CR; Carey TE; Prince ME
    Head Neck; 2015 Mar; 37(3):317-26. PubMed ID: 24415402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
    Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
    Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.